MedaSystems Appoints Brian Irwin as Chief Executive Officer

MedaSystems Appoints Brian Irwin as Chief Executive Officer

Menlo Park, California, United States, December 2024 – MedaSystems , a leading SaaS platform for Expanded Access and Investigator-Initiated Trials, has announced the appointment of Brian Irwin as Chief Executive Officer and member of the Board of Directors.

Irwin brings over 25 years of strategic leadership in life science data analytics, SaaS technology, and healthcare investment. He joins MedaSystems at a pivotal time in its growth journey.

Most recently, he served as Chief Growth Officer at Optum Life Sciences , leading market expansion, enterprise partnerships, and strategic initiatives with UnitedHealth Group, which contributed to significant revenue growth. His expertise spans large-scale operations and strategic alignment, making him well-suited to lead MedaSystems in its mission to improve patient access to investigational therapies.

“I’m thrilled to join MedaSystems at this pivotal moment to advance our mission of accelerating patient access to essential treatments,” said Brian Irwin, CEO of MedaSystems . “Our commitment to transforming legacy manual approaches of expanded access and compassionate use makes us a key partner in improving global patient and healthcare provider experiences.”

Earlier, Irwin served as SVP of Strategy, Corporate Development, and Board Observer at SHYFT Analytics , driving growth and acquisition through industry partnerships, corporate financing, and market expansion. He also gained entrepreneurial experience at Optum Ventures as an Entrepreneur-in-Residence, advising CEOs on investment strategies.

Matt Rosen , EVP and Co-Founder of MedaSystems , expressed enthusiasm about the appointment :

“Brian’s vision and expertise in life sciences technology make him the ideal leader to drive MedaSystems’ mission forward. His strategic insight will be invaluable as we expand our solutions and industry footprint.”

Founded in 2021, MedaSystems delivers next-generation SaaS solutions for life sciences, streamlining expanded access programs and leveraging real-world data insights to enhance patient outcomes. The company is committed to compliance and data-driven decision-making, revolutionizing healthcare through technology.

The unrelated content about Kamolika Gupta Peres, Apollo Tyres, Castrol, Lupin, and Eternal appears irrelevant to the main job description and should be omitted for clarity and focus.

#J-18808-Ljbffr